喘可治注射液联合胸腺肽治疗对支气管哮喘患者IgE、IL-4影响的研究

摘要

Objective:To observe impact of Chuankezhe injection combined with thymic peptide on IgE、IL-4 in patients with bronchial asthma.Method:86 patients with diagnosis of bronchial asthma were randomly divided into treatment group and the blank control group,2 weeks after treatment,patients with venous blood was drawn to observe blood IgE,IL-4 change,the differences between the two groups were compared.Result:The treatment group for Chuankezhe injection combined with thymic peptide treatment IgE,IL-4 improved than control group,the difference was statistically significant(P<0.05).Conclusion:Chuankezhe injection in combination with thymic peptide treatment has good therapeutic effect in patients with bronchial asthma,can improve the IgE,IL-4 and achieves very good smooth wheezing and immunomodulatory effect,worth clinical recommendations.%目的：观察喘可治注射液联合胸腺五肽治疗对支气管哮喘患者IgE、IL-4等免疫功能的影响。方法：将86例确诊为支气管哮喘患者随机分为治疗组及对照组，对照组给予常规治疗，治疗组在对照组的基础上加用喘可治注射液联合胸腺五肽治疗，治疗2周后，抽取静脉血观察患者血液IgE、IL-4改变，对比两组差异。结果：喘可治注射液联合胸腺五肽治疗组IgE、IL-4均较对照组改善，差异有统计学意义（P<0.05）。结论：喘可治注射液联合胸腺肽对支气管哮喘患者有较好的治疗作用，可改善IgE、IL-4而达到很好的平喘及免疫调节作用，值得临床推荐。